Limongi Tania, Susa Francesca, Cauda Valentina
Department of Applied Science and Technology, Politecnico di Torino, Corso Duca degli Abruzzi 24, 10129 Turin, Italy.
Hematol Med Oncol. 2019 Jun 28;4:1000183. doi: 10.15761/hmo.1000183.
Nanotechnology, as an interdisciplinary science, combines engineering, physics, material sciences, and chemistry with the biomedicine knowhow, trying the management of a wide range of diseases. Nanoparticle-based devices holding tumor imaging, targeting and therapy capabilities are formerly under study. Since conventional hematological therapies are sometimes defined by reduced selectivity, low therapeutic efficacy and many side effects, in this review we discuss the potential advantages of the NPs' use in alternative/combined strategies. In the introduction the basic notion of nanomedicine and nanoparticles' classification are described, while in the main text nanodiagnostics, nanotherapeutics and theranostics solutions coming out from the use of a wide-ranging NPs availability are listed and discussed.
Hematol Med Oncol. 2019-6-28
Vet J. 2015-8
Front Bioeng Biotechnol. 2017-12-18
Polymers (Basel). 2022-3-17
Health Sci Rep. 2025-5-19
Curr Med Chem. 2018
Health Sci Rep. 2025-5-19
ADMET DMPK. 2023-9-26
Materials (Basel). 2021-11-28
Nanomaterials (Basel). 2019-4-4
Adv Sci (Weinh). 2019-1-13
Front Pharmacol. 2019-3-11
Nanomedicine. 2019-3-21
Nanomedicine (Lond). 2019-4